Cardiovascular Disease Affects Many Lives
Scripps Research is forging new scientific frontiers to address the global burden of cardiovascular disease.
Cardiovascular disease is the number one cause of death worldwide.Get Curious
Our dedicated researchers are delivering innovative diagnostics and therapeutics to keep hearts beating.
Cardiovascular disease encompasses a range of conditions that affect a person’s heart and blood vessels—from coronary artery disease and arrhythmias (irregular heartbeats) to heart defects and stroke. Thanks to scientific and medical advances in recent decades, significant progress has been made in preventing and treating cardiovascular disease. Yet, it remains the number one cause of death worldwide. At Scripps Research, we are committed to changing that.
We are pioneering state-of-the-art genomics and molecular biology to uncover the underlying mechanisms of cardiovascular disease and to illuminate the role of genetics and lifestyle in disease risk. Combining our expertise in foundational sciences with our exceptional translational and clinical research teams, we are turning discoveries into therapies.
Using cutting-edge sensors and artificial intelligence technologies, we are developing ways to diagnose and monitor patients—research that is essential to tailoring prevention and treatment to the individual. Rapidly testing ideas in our drug discovery facilities, we are identifying and perfecting new medicines for cardiovascular disease.
We are transforming medicine, with the patient’s interests at heart.
Treatment Tailored to the Patient
Our scientists showed that wearing mobile health devices greatly improved the rate of diagnosis for atrial fibrillation (AFib).
Researchers at Calibr, our drug discovery division, have developed an experimental drug that regenerates heart muscle.
Using genome editing, we can remove a heart disease risk locus from DNA, preventing blood vessel cell abnormalities.
Our smartphone app provides users an estimated genetic risk score for coronary artery disease.